瑞銀:維持中芯國際(0981.HK)“沽售”評級 予目標價15港元
瑞銀髮研報指,美國可能對中芯國際(0981.HK)的設備採購實施更嚴格的控制,該行將繼續關注美國限制的任何潛在發展,但方向似乎變得更加嚴格,以限制中芯國際獲取先進技術。該行維持其“沽售”評級,H股目標價15港元。
該行指,中芯國際的12英寸和8英寸晶圓廠運營已獲得關鍵的美國許可批准,包括用於14納米FinFET的材料和設備部件,但在產能增加方面,中芯國際只能在2021年擴展成熟的12英寸和8英寸晶圓,2022年進一步擴展14納米FinFET目前可見度較低,任何潛在的限制變化都可能導致更多的不確定性。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.